Early Energy Deficit in Huntington Disease: Identification of a Plasma Biomarker Traceable during Disease Progression

Overview of attention for article published in PLOS ONE, July 2007

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (63rd percentile)
Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter: 1 X user

patent: 1 patent

Citations

dimensions_citation: 201 Dimensions

Readers on

mendeley: 144 Mendeley

Summary X Patents Dimensions citations

So far, Altmetric has seen 1 patent that references this research output.

Anaplerotic therapy of huntington disease and other polyglutamine diseases

Grant US-9717705-B2

United States of America

This page shows the most recent patents that mention this research output.

Click here to find out how to access more activity.